Alivus Life Sciences standalone net profit rises 36.41% in the September 2025 quarter
Sales rise 16.00% to Rs 587.98 crore
Net profit of Alivus Life Sciences rose 36.41% to Rs 130.03 crore in the quarter ended September 2025 as against Rs 95.32 crore during the previous quarter ended September 2024. Sales rose 16.00% to Rs 587.98 crore in the quarter ended September 2025 as against Rs 506.88 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var.Sales587.98506.88 16 OPM %30.4726.51 -PBDT192.58142.55 35 PBT174.14127.46 37 NP130.0395.32 36Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Nov 07 2025 | 7:41 AM IST